Good Jennifer L's Form 4 filing
Trevi Therapeutics, Inc. (TRVI) · filed Sep 9, 2024
- Accession no.
- 0000950170-24-104804
- Filed
- Sep 9, 2024
- Trade date
- Sep 6-9, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $18.4K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Good Jennifer LCIK 0001229245 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2024 | Common Stock | MOption exerciseAcquired | +4,219 | $1.43 | +$6,033.17 | 217,532 | Direct | |
| Sep 6, 2024 | Common Stock | SSaleDisposed | −4,219 | $3.03 | −$12,783.57 | 213,313 | Direct | |
| Sep 9, 2024 | Common Stock | MOption exerciseAcquired | +1,840 | $1.43 | +$2,631.2 | 215,153 | Direct | |
| Sep 9, 2024 | Common Stock | SSaleDisposed | −1,840 | $3.04 | −$5,593.6 | 213,313 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2024 | Common Stock | MOption exerciseDisposed | −4,219 | $0.00 | $0 | 1,840 | Direct | |
| Sep 9, 2024 | Common Stock | MOption exerciseDisposed | −1,840 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.